Skip to main content

vizz

Generic: aceclidine·Code: LNZ100

vizz: sourced relationships with 1 company · 1 FDA decision.

vizz evidence translation

What we can confirm

What it means

Source-backed records connect vizz to LENZ; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could vizz → LENZ affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
LENZ Therapeutics, Inc. (LENZ)
licensee · Reported 2026-03-24 · Current development: unknownSource
Approved
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults ( 1 ).(LENZ)FDA ↗
NDA218585Type 1 - New Molecular EntityStandardOphthalmicSolution/Drops

Frequently asked questions

Which companies have sourced relationships with vizz?

vizz has dated SEC/FDA relationship records for LENZ Therapeutics, Inc..

What is vizz's latest FDA decision?

The most recent tracked FDA decision for vizz is Approval for 1 INDICATIONS AND USAGE VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults ( 1 )., dated July 31, 2025.